Download Making Sense of Lid Margin Disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Meningococcal disease wikipedia , lookup

Schistosomiasis wikipedia , lookup

Pandemic wikipedia , lookup

Chagas disease wikipedia , lookup

Leptospirosis wikipedia , lookup

Onchocerciasis wikipedia , lookup

Leishmaniasis wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Visceral leishmaniasis wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Multiple sclerosis wikipedia , lookup

Transcript
Making Sense of Lid Margin
Disease
Course Description
This course will address lid margin disease and related ocular surface disease
disorders. It will cover the basic etiology and presentation of lid margin disease
in its various forms. We will also discuss a systematic approach to diagnosing
and treating often-overlooked forms of lid margin disease.
Course Length 2 Hrs
Scot Morris, O.D.
e: [email protected]
COPE # 23476-AS
Audience: General
Speaker Disclosure
In the last 24 months I have received compensation in some fashion from the following entities for the stated reasons.
CONSULTANT/ADVISORY BOARD: Allergan, Bausch & Lomb, Essilor, Eyefinity/Officemate, ECR Vault, EyeMaginations,
EyeStar TV, GPN, MARCO, Odyssey Medical, Opti-align
SPEAKER/EDUCATOR: Alcon, Allergan, CIBA, Essilor, EyeMaginations, MARCO, Vistakon
GRANT RECIPIENT: Biosciences, Alcon, Allergan, ELOA, Review of Optometry
AUTHOR/EDITOR: Optometric Management, Optometric Office, Optometry Times, Review of Optometry
COMPANY OWNERSHIP: Ocular Technology Solutions, Morris Education & Consulting Associates, LLC, Eye Consultants
of Colorado, LLC
OTHER: Ocular Surface Society of Optometry (Treasurer)
Course Objectives
1.
2.
3.
4.
5.
6.
7.
8.
Discuss the financial implications of going electronic
Compare and contrast the electronic office to the paper office
Describe workflow analysis
List the real vs. perceived practice needs as they relate to EHR
List hardware and software requirements
Describe product analysis options
Describe integration options and points of concern
Describe data conversion considerations
Morris Education & Consulting Associates, LLC
303.250.0376
www.mecaconsulting.com
[email protected]
Scot Morris, O.D.
e: [email protected]
Abridged Course Notes
I.
What is Lid Margin Disease
A. Symptoms
B. Presentation
"Take-Home"
Notes
1. Blepharitis
a) Anterior
(1) Infectious
(a) Common Pathogens
b) Posterior
(1) Seborrheic Bleph
(2) Seborrheic Bleph with Meibomian
Seborrhea
(3) Seborrheic Bleph with Meibomitis
(4) Primary Meibomitis
(5) MGD
(6) MG Seborrhea
2. Meibomian Gland Dysfunction
a) Morphological Changes
(1) Duct
(2) Orifice
(3) Gland
(4) Expression
(a) Volume
(b) Quality
(c) Associated Conditions
3. Lid Distribution Issues
a)
b)
c)
II. Who Gets Lid Margin
Apposition
Closure
Distribution
Disease
1. Lipid Issues
2. Allergies
3. Chronic Topical Meds
4. Dry Eyes
5. Mechanical Issues
"To Do List"
Morris Education & Consulting Associates, LLC
303.250.0376
www.mecaconsulting.com
[email protected]
Scot Morris, O.D.
e: [email protected]
Abridged Course Notes
"Take-Home"
III. Why Is It There
IV. How do we look for lid margin Disease
A. Diagnostic Protocol
Notes
1. History
2. Lids/Lid Margin
3. Palpebral Conjunctiva
4. Tear Film
5. Ocular Surface
6. Tear Production
7. Tear Stability
8. Drainage System
9. Meibomian Gland Evaluation
V. How Do We Treat It
A. Traditional Therapy
1. Antibiotics/Combo’s
2. Hot Compresses
3. Lid Expression
4. Lid Hygiene
5. Oral Medications
6. Other Topical Medications
B. New Thoughts on Disease Management
1. Protect Patients health and vision
2. Provide Comfort
3. Arrest Disease Progression
4. Decrease negative inflammation
5. Control secondary cellular changes
6. Restore normal anatomy & Physiology
C. New Thoughts on Lid Margin Disease Therapy
"To-Do List"
1. Dealing with Infection
a) Pathogen Eradication
2. Dealing with Inflammation
a) Who are the inflammatory players on
the lid margin
b) Direct Immunomodulation
c) Indirect Immunomodulation
3. Topical Therapeutic Options and Alternatives
Morris Education & Consulting Associates, LLC
303.250.0376
www.mecaconsulting.com
[email protected]
Abridged Course Notes
Scot Morris, O.D.
e: [email protected]
VI. Why do We Treat It
A. What if we don’t
1. Financial
a) Optical Remakes
b) Lost medical revenue
c) Lost patients
"Take-Home"
Notes
2. Medical Ethics & Clinical Practice
a) LMD Progression
b) Severe Dry Eye
B. The Practice Management Protocol
1. Proceed
a) Game Plan
(1) Plan
(2) Train
(3) Market
b) Practice Buy-In
c) Tools
2. Practice
a) Approach
(1) Medical Mindset
(2) Schedule Alterations
3. Profit
a) Coding Problems and Pitfalls
b) Show me the Money
c) Get out of your own way
"To Do List"
Morris Education & Consulting Associates, LLC
303.250.0376
www.mecaconsulting.com
[email protected]